NHS electronic prescribing systems and hospital formularies often default to generic names to maintain consistency and prevent medication errors across healthcare settings
Real-world prescribing data shows approximately 60% of patients remain on 1.7 mg or 2.0 mg, while 25% stabilize at 1.0 mg, and 15% require dose reduction due to side effects
(Other combination options include WP Thyroid and Nature-Throid, however, these medications are currently unavailable following a voluntary recall in 2020.) In my survey of over 2,000 readers, 76 percent reported improved energy while taking compounded T3/T4, 74 percent while taking Armour Thyroid*, 74 percent with Cytomel, and 72 percent with Nature-Throid
All AD-linked biomarkers appeared to decrease significantly even with limited exposure to the peptide
This treatment is particularly beneficial for those experiencing dehydration, nutrient deficiencies, or stress-related fatigue